These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34332063)

  • 1. Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review.
    Jansook P; Hnin HM; Loftsson T; Stefánsson E
    Int J Pharm; 2021 Sep; 606():120955. PubMed ID: 34332063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents.
    Bragagni M; Bozdag M; Carta F; Scozzafava A; Lanzi C; Masini E; Mura P; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(18):6223-7. PubMed ID: 26319622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin complexes of sulfonamide carbonic anhydrase inhibitors as long-lasting topically acting antiglaucoma agents.
    Maestrelli F; Mura P; Casini A; Mincione F; Scozzafava A; Supuran CT
    J Pharm Sci; 2002 Oct; 91(10):2211-9. PubMed ID: 12226848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising complexes of acetazolamide for topical ocular administration.
    Granero GE; Longhi MR
    Expert Opin Drug Deliv; 2010 Aug; 7(8):943-53. PubMed ID: 20565335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
    J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical overview of brinzolamide.
    DeSantis L
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S119-29. PubMed ID: 10665514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?
    Stoner A; Harris A; Oddone F; Belamkar A; Verticchio Vercellin AC; Shin J; Januleviciene I; Siesky B
    Br J Ophthalmol; 2022 Oct; 106(10):1332-1337. PubMed ID: 34433550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy.
    Hiett JA; Dockter CA
    Optom Clin; 1992; 2(4):97-112. PubMed ID: 1286242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R; Ticho U
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J
    Klin Oczna; 1997; 99(3):217-20. PubMed ID: 9456571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.
    Sugrue MF
    Prog Retin Eye Res; 2000 Jan; 19(1):87-112. PubMed ID: 10614682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors. Part 79. Synthesis of topically acting sulfonamides incorporating GABA moieties in their molecule, with long-lasting intraocular pressure-lowering properties.
    Mincione G; Menabuoni L; Briganti F; Mincione F; Scozzafava A; Supuran CT
    Eur J Pharm Sci; 1999 Dec; 9(2):185-99. PubMed ID: 10620731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E; Stefánsson E; Bjarnadóttir G; Sigurjónsdóttir JF; Gudmundsdóttir G; Masson M; Loftsson T
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical carbonic anhydrase inhibitors: potential adjuvants to glaucoma therapy in the future.
    Scott BT
    Optom Vis Sci; 1994 May; 71(5):332-8. PubMed ID: 8065709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?
    Borras J; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
    Bioorg Med Chem; 1999 Nov; 7(11):2397-406. PubMed ID: 10632049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors. Water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic/heterocyclic sulfonamides: is the tail more important than the ring?
    Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G; Supuran CT
    J Enzyme Inhib; 1999; 14(6):457-74. PubMed ID: 10536879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical drug delivery to the eye: dorzolamide.
    Loftsson T; Jansook P; Stefánsson E
    Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma.
    Portellos M; Buckley EG; Freedman SF
    J AAPOS; 1998 Feb; 2(1):43-7. PubMed ID: 10532366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma and the applications of carbonic anhydrase inhibitors.
    Scozzafava A; Supuran CT
    Subcell Biochem; 2014; 75():349-59. PubMed ID: 24146387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.